Log in to save to my catalogue

Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with...

Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2902963604

Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors

About this item

Full title

Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors

Publisher

Cham: Springer International Publishing

Journal title

Targeted oncology, 2024-01, Vol.19 (1), p.13-28

Language

English

Formats

Publication information

Publisher

Cham: Springer International Publishing

More information

Scope and Contents

Contents

Malignant pleural mesothelioma (MPM) is a rare and challenging cancer associated with asbestos fiber exposure, which offers limited treatment options. Historically, platinum-based chemotherapy has been the primary approach, but recent developments have introduced immunotherapy as a promising alternative for the treatment of this disease. Neverthele...

Alternative Titles

Full title

Malignant Pleural Mesothelioma: Staging and Radiological Response Criteria in Patients Treated with Immune Checkpoint Inhibitors

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2902963604

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2902963604

Other Identifiers

ISSN

1776-2596

E-ISSN

1776-260X

DOI

10.1007/s11523-023-01017-w

How to access this item